H. Meier‐Kriesche

发表

Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease.

J. Schold, H. Meier‐Kriesche, T. Srinivas, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Long‐Term Renal Allograft Survival in the United States: A Critical Reappraisal

K. Lamb, H. Meier‐Kriesche, S. Lodhi, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Calcineurin inhibitors in kidney transplantation: friend or foe?

H. Meier‐Kriesche, M. Casey, 2011, Current opinion in nephrology and hypertension.

The influence of pancreas after kidney transplantation on patient survival and kidney allograft function

H. Meier‐Kriesche, D. Foley, 2006 .

Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?

J. Schold, H. Meier‐Kriesche, B. Kaplan, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Gender imbalance in living donor renal transplantation.

R. Merion, D. Campbell, H. Meier‐Kriesche, 2002, Transplantation.

The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.

D. Horn, H. Meier‐Kriesche, M. Pfaller, 2012, Diagnostic microbiology and infectious disease.

Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era

J. Schold, H. Meier‐Kriesche, T. Srinivas, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death.

H. Meier‐Kriesche, B. Kaplan, J. Arndorfer, 2002, Transplantation.

Associations Between EBV Serostatus and Organ Transplant Type in PTLD Risk: An Analysis of the SRTR National Registry Data in the United States

K. Lamb, H. Meier‐Kriesche, V. Dharnidharka, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Renal transplantation: a half century of success and the long road ahead.

H. Meier‐Kriesche, B. Kaplan, 2004, Journal of the American Society of Nephrology : JASN.

The Effect of Renal Insufficiency on Mycophenolic Acid Protein Binding

L. Shaw, M. Korecka, S. Gruber, 1999, Journal of clinical pharmacology.

Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients

H. Meier‐Kriesche, M. Weir, L. Gallon, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Are We Frozen in Time? Analysis of the Utilization and Efficacy of Pulsatile Perfusion in Renal Transplantation

J. Schold, R. Howard, H. Meier‐Kriesche, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Renal transplantations performed using non–heart-beating organ donors: going back to the future?1

R. Merion, H. Meier‐Kriesche, B. Kaplan, 2002, Transplantation.

Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease.

J. Schold, J. Wingard, H. Meier‐Kriesche, 2004, Blood.

Pharmacology of calcineurin antagonists.

H. Meier‐Kriesche, B. Kaplan, M. Kapturczak, 2004, Transplantation proceedings.

Solid Organ Allograft Survival Improvement in the United States: The Long‐Term Does Not Mirror the Dramatic Short‐Term Success

K. Lamb, H. Meier‐Kriesche, S. Lodhi, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunosuppression: Evolution in Practice and Trends, 1994–2004

J. Trotter, J. Fung, E. Milford, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States

J. Schold, H. Meier‐Kriesche, T. Srinivas, 2009, Transplant international : official journal of the European Society for Organ Transplantation.

Mycophenolate mofetil in solid-organ transplantation

H. Meier‐Kriesche, T. Srinivas, B. Kaplan, 2003, Expert opinion on pharmacotherapy.

Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2

H. Meier‐Kriesche, B. Kaplan, R. Baliga, 2003, Transplantation.

Across all solid organs, adolescent age recipients have worse transplant organ survival than younger age children: A US national registry analysis

Jie Zheng, K. Schechtman, K. Lamb, 2015, Pediatric transplantation.

The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation

A. Gaber, S. Busque, S. Mulgaonkar, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Mycophenolate mofetil: long-term outcomes in solid organ transplantation

J. Schold, H. Meier‐Kriesche, T. Srinivas, 2006, Expert review of clinical immunology.

Pharmacokinetics of mycophenolic acid in renal insufficiency.

L. Shaw, M. Korecka, H. Meier‐Kriesche, 2000, Therapeutic drug monitoring.

Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations.

H. Meier‐Kriesche, B. Kaplan, 2000, Clinical therapeutics.

The Overlapping Risk Profile Between Dialysis Patients Listed and Not Listed for Renal Transplantation

J. Schold, H. Meier‐Kriesche, T. Srinivas, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Mycophenolate mofetil-based immunosuppressive minimization and withdrawal strategies in renal transplantation: possible risks and benefits

H. Meier‐Kriesche, 2006, Current opinion in nephrology and hypertension.

Mycophenolate Mofetil Initiation in Renal Transplant Patients at Different Times Posttransplantation: The TranCept Switch Study

P. Kes, L. Rostaing, H. Haller, 2011, Transplantation.

Kidneys from Deceased Donors: Maximizing the Value of a Scarce Resource

J. Schold, H. Meier‐Kriesche, B. Kaplan, 2005 .

Poor Predictive Value of Serum Creatinine for Renal Allograft Loss

H. Meier‐Kriesche, B. Kaplan, Jesse Schold and, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Differences in etiology for graft loss in female renal transplant recipients.

A. Ojo, H. Meier‐Kriesche, B. Kaplan, 2001, Transplantation proceedings.

Obesity and kidney transplantation.

H. Meier‐Kriesche, T. Srinivas, 2013, Seminars in nephrology.

Response to "Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared with lisinopril".

W. Bennett, H. Meier‐Kriesche, T. Srinivas, 2002, Transplantation.

Interventional trials involving patients cannot be performed safely without a control group treated with the standard of care.

J. Schold, H. Meier‐Kriesche, H. Ekberg, 2007, Transplantation.

INCREASED IMPACT OF ACUTE REJECTION ON CHRONIC ALLOGRAFT FAILURE IN RECENT ERA

A. Nagler, A. Ojo, A. Toren, 2000, Transplantation.

Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis?

J. Schold, H. Meier‐Kriesche, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration1

H. Meier‐Kriesche, B. Kaplan, M. Liebman, 2003, Transplantation.

Effect of waiting time on renal transplant outcome.

F. Port, A. Ojo, H. Meier‐Kriesche, 2000, Kidney international.

Relationship of recipient age and development of chronic allograft failure.

F. Port, A. Ojo, H. Meier‐Kriesche, 2000, Transplantation.

African-American renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategies.

A. Ojo, H. Meier‐Kriesche, B. Kaplan, 2000, Transplantation.

The Pivotal Impact of Center Characteristics on Survival of Candidates Listed for Deceased Donor Kidney Transplantation

J. Schold, N. Chumbler, R. Duncan, 2009, Medical care.

Renal transplantation in the elderly

J. Schold, H. Meier‐Kriesche, B. Kaplan, 2006 .

The Impact of Mycophenolate Mofetil on Long-Term Outcomes in Kidney Transplantation

J. Schold, H. Meier‐Kriesche, T. Srinivas, 2005, Transplantation.

Elevated Incidence of Posttransplant Erythrocytosis After Simultaneous Pancreas Kidney Transplantation

J. Schold, H. Meier‐Kriesche, G. Guerra, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Increased immunosuppressive vulnerability in elderly renal transplant recipients.

L. Agodoa, A. Ojo, K. Lake, 2000, Transplantation.

Long-term benefit of kidney-pancreas transplants in type 1 diabetics.

R. Wolfe, L. Agodoa, F. Port, 2001, Transplantation proceedings.

Fixed‐ or Controlled‐Dose Mycophenolate Mofetil with Standard‐ or Reduced‐Dose Calcineurin Inhibitors: The Opticept Trial

S. Mulgaonkar, H. Meier‐Kriesche, B. Kaplan, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Death After Graft Loss: An Important Late Study Endpoint in Kidney Transplantation

H. Meier‐Kriesche, B. Kaplan, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study.

J. Schold, P. Halloran, H. Meier‐Kriesche, 2009, Clinical journal of the American Society of Nephrology : CJASN.

The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease

J. Schold, H. Meier‐Kriesche, E. Dunbar, 2008, Haematologica.

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

H. Meier‐Kriesche, C. V. van Buren, J. Podbielski, 1998 .

Should We Be Performing Pancreas Transplants?

M. Stegall, H. Meier‐Kriesche, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A limited sampling strategy for estimating sirolimus area-under-the-concentration curve.

H. Meier‐Kriesche, B. Kaplan, B. Kahan, 1997, Clinical chemistry.

Value of Posttransplant Antibody Tests in the Evaluation of Patients with Renal Graft Dysfunction

J. Schold, D. Dragun, H. Meier‐Kriesche, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

J. Schold, J. Wingard, H. Meier‐Kriesche, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The effects of renal transplantation on peripheral blood dendritic cells

J. Schold, H. Meier‐Kriesche, B. Kaplan, 2005, Clinical transplantation.

Calcineurin inhibitor‐free immunosuppression in kidney transplantation

H. Meier‐Kriesche, T. Srinivas, G. Guerra, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

Everolimus in renal transplantation

H. Meier‐Kriesche, T. Srinivas, B. Kaplan, 2002 .

Death after graft loss: a novel endpoint for renal transplantation.

H. Meier‐Kriesche, B. Kaplan, 2001, Transplantation proceedings.

The effect of body mass index on long-term renal allograft survival.

G. Friedman, H. Meier‐Kriesche, B. Kaplan, 1999, Transplantation.

Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients.

F. Port, A. Ojo, H. Meier‐Kriesche, 2001, Journal of the American Society of Nephrology : JASN.

Excellent outcome of renal transplantation in patients with Fabry's disease.

A. Ojo, G. Friedman, H. Meier‐Kriesche, 2000, Transplantation.

Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation.

H. Meier‐Kriesche, T. Dubose, K. Finkel, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Noninferiority Trial: Don't Don't Do It

H. Meier‐Kriesche, T. Srinivas, B. Kaplan, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Trials and Tribulations of Steroid Withdrawal After Kidney Transplantation

H. Meier‐Kriesche, B. Kaplan, J. Magee, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunosuppressive strategies to improve outcomes of kidney transplantation.

H. Meier‐Kriesche, B. Kaplan, I. Tang, 2007, Seminars in nephrology.

Mycophenolate Mofetil/Sirolimus Compared to Other Common Immunosuppressive Regimens in Kidney Transplantation

J. Schold, H. Meier‐Kriesche, T. Srinivas, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Correlation between pretransplantation test dose cyclosporine pharmacokinetic profiles and posttransplantation sirolimus blood levels in renal transplant recipients.

H. Meier‐Kriesche, B. Kaplan, B. Kahan, 1999, Therapeutic drug monitoring.

Mycophenolic Acid Exposure in High- and Low-Weight Renal Transplant Patients After Dosing With Mycophenolate Mofetil in the Opticept Trial

L. Shaw, H. Meier‐Kriesche, B. Kaplan, 2010, Therapeutic drug monitoring.

Long-term graft survival with neoral and tacrolimus: a paired kidney analysis.

J. Schold, H. Meier‐Kriesche, B. Kaplan, 2003, Journal of the American Society of Nephrology : JASN.

Improvement in hypercalcemia with cinacalcet after kidney transplantation.

J. Schold, R. Howard, H. Meier‐Kriesche, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Renal function with cyclosporine C2 monitoring, enteric‐coated mycophenolate sodium and basiliximab: a 12‐month randomized trial in renal transplant recipients

P. Kuo, G. Klintmalm, E. Benedetti, 2007, Clinical transplantation.

Sirolimus with Neoral Versus Mycophenolate Mofetil with Neoral is Associated with Decreased Renal Allograft Survival

H. Meier‐Kriesche, B. Kaplan, R. Gordon, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain.

S. Mulgaonkar, G. Friedman, H. Meier‐Kriesche, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Exponentially increased risk of infectious death in older renal transplant recipients.

A. Ojo, H. Meier‐Kriesche, B. Kaplan, 2001, Kidney international.

Effects of Blood Transfusions Given After Renal Transplantation

J. Schold, H. Meier‐Kriesche, J. Scornik, 2009, Transplantation.

Sirolimus in Combination with Tacrolimus Is Associated with Worse Renal Allograft Survival Compared to Mycophenolate Mofetil Combined with Tacrolimus

J. Schold, R. Howard, H. Meier‐Kriesche, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunosuppression in Elderly Renal Transplant Recipients

H. Meier‐Kriesche, B. Kaplan, 2001, Drugs & aging.

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation.

H. Meier‐Kriesche, C. V. van Buren, J. Podbielski, 1999, Transplantation.

Allograft loss in renal transplant recipients with Fabry's disease and activated protein C resistance.

S. Mulgaonkar, G. Friedman, H. Meier‐Kriesche, 2000, Transplantation.

INTERACTION OF MYCOPHENOLATE MOFETIL AND HLA MATCHING ON RENAL ALLOGRAFT SURVIVAL

A. Ojo, H. Meier‐Kriesche, B. Kaplan, 2001, Transplantation.

Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal.

N. Davies, B. Maes, H. Meier‐Kriesche, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of Sirolimus Withdrawal in Patients with Deteriorating Renal Function

J. Schold, R. Howard, H. Meier‐Kriesche, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Factors Associated With Long-Term Renal Allograft Survival

H. Meier‐Kriesche, T. Srinivas, B. Kaplan, 2002, Therapeutic drug monitoring.

Hepatitis C antibody status and outcomes in renal transplant recipients.

A. Ojo, H. Meier‐Kriesche, B. Kaplan, 2001, Transplantation.

Access to quality: evaluation of the allocation of deceased donor kidneys for transplantation.

J. Schold, N. Chumbler, R. Howard, 2005, Journal of the American Society of Nephrology : JASN.

Pulsatile Pump Decreases Risk of Delayed Graft Function in Kidneys Donated After Cardiac Death

K. Lamb, H. Meier‐Kriesche, S. Lodhi, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Randomized calcineurin inhibitor cross over study to measure the pharmacokinetics of co‐administered enteric‐coated mycophenolate sodium

H. Meier‐Kriesche, B. Kaplan, R. Schmouder, 2005, Clinical transplantation.

Blood Transfusions in Organ Transplant Patients: Mechanisms of Sensitization and Implications for Prevention

H. Meier‐Kriesche, J. Scornik, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates.

R. Wolfe, L. Agodoa, F. Port, 2001, Journal of the American Society of Nephrology : JASN.

Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant.

J. Schold, A. Sehgal, H. Meier‐Kriesche, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A Paired Donor Kidney Analysis1

H. Meier‐Kriesche, B. Kaplan, 2002, Transplantation.

Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study.

J. Schold, P. Halloran, H. Meier‐Kriesche, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.

Kieren A Marr, E. Anaissie, D. Horn, 2012, The Journal of infection.

Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study

D. Horn, H. Meier‐Kriesche, S. Huprikar, 2014, HIV/AIDS.

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

D. Horn, H. Meier‐Kriesche, M. Pfaller, 2012, Diagnostic microbiology and infectious disease.

Overview of Large Database Analysis in Renal Transplantation

J. Schold, H. Meier‐Kriesche, B. Kaplan, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

J. Schold, J. Wingard, H. Meier‐Kriesche, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lack of significant improvements in long‐term allograft survival in pediatric solid organ transplantation: A US national registry analysis

Jie Zheng, K. Schechtman, K. Lamb, 2015, Pediatric transplantation.

Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation

H. Meier‐Kriesche, T. Dubose, K. Finkel, 2001, Critical care medicine.

Mycophenolate Sodium Does Not Reduce the Incidence of GI Adverse Events Compared with Mycophenolate Mofetil

N. Davies, B. Maes, H. Meier‐Kriesche, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A limited sampling strategy for the estimation of Neoral AUCs in pediatric patients

R. Portman, H. Meier‐Kriesche, M. Ferris, 1999, Pediatric Nephrology.

THE IMPACT OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION ON LONG-TERM PATIENT SURVIVAL1

R. Wolfe, L. Agodoa, F. Port, 2001, Transplantation.

Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients

H. Meier‐Kriesche, M. First, W. Fitzsimmons, 2014, Transplantation.

Prolonged Immunosuppression Preserves Nonsensitization Status After Kidney Transplant Failure

H. Meier‐Kriesche, M. Casey, L. Kayler, 2014, Transplantation.

Removal of basiliximab by plasmapheresis.

H. Meier‐Kriesche, B. Kaplan, C. Gerbeau, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis.

S. Mulgaonkar, G. Friedman, H. Meier‐Kriesche, 2001, Transplantation.

Are we making progress in kidney transplantation?

K. Mekeel, H. Meier‐Kriesche, B. Kaplan, 2006 .

Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients.

H. Meier‐Kriesche, B. Kaplan, J. Arndorfer, 2002, Journal of the American Society of Nephrology : JASN.

GENDER DIFFERENCES IN THE RISK FOR CHRONIC RENAL ALLOGRAFT FAILURE

A. Ojo, H. Meier‐Kriesche, B. Kaplan, 2001, Transplantation.

A Lifetime Versus a Graft Life Approach Redefines the Importance of HLA Matching in Kidney Transplant Patients

J. Schold, H. Meier‐Kriesche, B. Susskind, 2009, Transplantation.

Renal allograft survival in patients with oxalosis.

H. Meier‐Kriesche, B. Kaplan, J. Arndorfer, 2002, Transplantation.

Use of intravenous immune globulin and rituximab for desensitization of highly human leukocyte antigen-sensitized patients awaiting kidney transplantation.

H. Meier‐Kriesche, J. Scornik, S. Rehman, 2010, Transplantation.

Preemptive Retransplantation for BK Virus Nephropathy: Successful Outcome Despite Active Viremia

B. Croker, R. Howard, H. Meier‐Kriesche, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Time to first graft loss as a risk factor for second renal allograft loss.

S. Gruber, A. Ojo, K. Lake, 2001, Transplantation proceedings.

Belatacept and Long-Term Outcomes in Kidney Transplantation.

L. Rostaing, H. Meier‐Kriesche, F. Vincenti, 2016, The New England journal of medicine.

Barriers to evaluation and wait listing for kidney transplantation.

J. Schold, A. Hall, H. Meier‐Kriesche, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result.

H. Meier‐Kriesche, T. Srinivas, Titte R Srinivas, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Posttransplant reduction in preexisting donor‐specific antibody levels after belatacept‐ versus cyclosporine‐based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT‐EXT

H. Meier‐Kriesche, C. Larsen, R. Bray, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

De novo donor‐specific antibodies in belatacept‐treated vs cyclosporine‐treated kidney‐transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT‐EXT studies

H. Meier‐Kriesche, C. Larsen, R. Bray, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly

H. Meier‐Kriesche, F. Vincenti, C. Larsen, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT‐EXT at 7 Years After Transplant

H. Meier‐Kriesche, T. Becker, P. O’Connell, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Long‐Term Outcomes in Belatacept‐ Versus Cyclosporine‐Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT‐EXT, a Phase III Randomized Study

L. Rostaing, H. Meier‐Kriesche, A. Durrbach, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Interaction between acute rejection and recipient age on long-term renal allograft survival.

H. Meier‐Kriesche, T. Srinivas, B. Kaplan, 2001, Transplantation proceedings.

Long‐Term Use of Mycophenolate Mofetil is Associated With a Reduction in the Incidence and Risk of Late Rejection

H. Meier‐Kriesche, B. Kaplan, R. Gordon, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The effect of Daclizumab in a high‐risk renal transplant population

S. Mulgaonkar, A. Ojo, G. Friedman, 2000, Clinical transplantation.

Role of Anti— Interleukin-2 Receptor Antibodies in Kidney Transplantation

H. Meier‐Kriesche, B. Kaplan, D. Cibrik, 2012, BioDrugs.

Best Allograft Survival from Share-35 Kidney Donors Occurs in Middle-Aged Adults and Young Children—An Analysis of OPTN Data

K. Lamb, H. Meier‐Kriesche, V. Dharnidharka, 2013, Transplantation.

A Limited Sampling Strategy for the Estimation of 12‐Hour SangCya and Neoral AUCs in Renal Transplant Recipients

A. Gaber, H. Meier‐Kriesche, B. Kaplan, 1999, Journal of clinical pharmacology.

A limited sampling strategy for the estimation of eight-hour neoral areas under the curve in renal transplantation.

R. Portman, H. Meier‐Kriesche, B. Kaplan, 1998, Therapeutic drug monitoring.

Kidney allograft survival: the long and short of it.

H. Meier‐Kriesche, S. Lodhi, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Deleterious effect of waiting time on renal transplant outcome.

F. Port, A. Ojo, H. Meier‐Kriesche, 2001, Transplantation proceedings.

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.

R. Wolfe, L. Agodoa, A. Ojo, 2000, Transplantation.

Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients.

H. Meier‐Kriesche, B. Kaplan, R. Gordon, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Outcomes of Kidney and Pancreas Transplantation

J. Schold, H. Meier‐Kriesche, T. Srinivas, 2011 .

The Success of Continued Steroid Avoidance After Kidney Transplantation in the US

J. Schold, H. Meier‐Kriesche, J. Magliocca, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Switching immunosuppression medications after renal transplantation--a common practice.

H. Meier‐Kriesche, K. Chi-Burris, A. Chu, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Need for individualized immunosuppression in elderly renal transplant recipients.

A. Ojo, K. Lake, H. Meier‐Kriesche, 2001, Transplantation proceedings.

Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols.

S. Mulgaonkar, G. Friedman, H. Meier‐Kriesche, 1999, Transplantation.

Mycophenolate mofetil decreases the risk for chronic renal allograft failure.

A. Ojo, D. Campbell, H. Meier‐Kriesche, 2001, Transplantation proceedings.

Recipient age as an independent risk factor for chronic renal allograft failure.

F. Port, A. Ojo, H. Meier‐Kriesche, 2001, Transplantation proceedings.

PANCREAS AFTER KIDNEY TRANSPLANTATION: A SIGNIFICANT RISK FACTOR FOR RENAL ALLOGRAFT LOSS

J. Schold, H. Meier‐Kriesche, A. Reed, 2004 .

The Impact of Pretransplant Dialysis on Outcomes in Renal Transplantation

J. Schold, H. Meier‐Kriesche, 2005, Seminars in dialysis.

CHAPTER 105 – Outcomes of Renal Transplantation

J. Schold, H. Meier‐Kriesche, T. Srinivas, 2010 .

A ‘Weight‐Listing’ Paradox for Candidates of Renal Transplantation?

J. Schold, R. Oberbauer, H. Meier‐Kriesche, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.

R. Howard, H. Meier‐Kriesche, A. Reed, 2005, Clinical transplants.

Obesity and kidney transplantation.

H. Meier‐Kriesche, T. Srinivas, 2006, Contributions to nephrology.

Pharmacokinetic Principles of Immunosuppressive Drugs

H. Meier‐Kriesche, T. Srinivas, B. Kaplan, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

RENAL TRANSPLANTATION: AN UPDATE FOR THE GENERAL NEPHROLOGIST

J. Schold, H. Meier‐Kriesche, 2005 .

Kidney Transplantation Halts Cardiovascular Disease Progression in Patients with End‐Stage Renal Disease

J. Schold, H. Meier‐Kriesche, T. Srinivas, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The Association of Candidate Mortality Rates With Kidney Transplant Outcomes and Center Performance Evaluations

J. Schold, R. Howard, H. Meier‐Kriesche, 2008, Transplantation.

The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent

H. Meier‐Kriesche, B. Kahan, K. Napoli, 1998, Clinical pharmacology and therapeutics.

Cyclosporine Microemulsion and Tacrolimus are Associated with Decreased Chronic Allograft Failure and Improved Long‐term Graft Survival as Compared with Sandimmune

H. Meier‐Kriesche, B. Kaplan, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

No robust conclusions to be drawn from clinical trials in the absence of an adequate control group

H. Meier‐Kriesche, H. Ekberg, 2007, Transplant International.

Preservation of Long‐term Renal Allograft Survival: A Challenge for the Years to Come

J. Schold, H. Meier‐Kriesche, B. Kaplan, 2005 .

Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared to Sandimmune.

H. Meier‐Kriesche, B. Kaplan, 2001, Transplantation proceedings.

Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity.

M. Abecassis, D. Kaufman, H. Meier‐Kriesche, 1999, Transplantation.

Association between admission hyperglycemia and length of stay after renal transplantation.

H. Meier‐Kriesche, M. Lansang, Amita Kathuria, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Withdrawal of mycophenolate mofetil in stable renal transplant recipients.

S. Mulgaonkar, G. Friedman, H. Meier‐Kriesche, 2000, Transplantation.

Interaction Between Donor and Recipient Age in Determining the Risk of Chronic Renal Allograft Failure

A. Ojo, H. Meier‐Kriesche, B. Kaplan, 2002, Journal of the American Geriatrics Society.

The Broad Spectrum of Quality in Deceased Donor Kidneys

J. Schold, H. Meier‐Kriesche, B. Kaplan, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of mycophenolate mofetil on long-term outcomes in African american renal transplant recipients.

A. Ojo, H. Meier‐Kriesche, B. Kaplan, 2000, Journal of the American Society of Nephrology : JASN.

Are We Ready to Give Up on Calcineurin Inhibitors?

D. Hricik, H. Meier‐Kriesche, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Efficacy of Daclizumab in an African-American and Hispanic renal transplant population

S. Mulgaonkar, G. Friedman, H. Meier‐Kriesche, 2000, Transplant International.

Reduced variability of Neoral pharmacokinetic studies in pediatric renal transplantation

R. Portman, H. Meier‐Kriesche, B. Kahan, 2000, Pediatric Nephrology.

A pharmacokinetic comparison of the corn oil versus microemulsion gelcap formulation of cyclosporin used de novo after renal transplantation

H. Meier‐Kriesche, B. Kahan, A. Amante, 1997, Transplant international : official journal of the European Society for Organ Transplantation.

Hiv/aids – Research and Palliative Care Dovepress Clinical Characteristics and Outcomes in 303 Hiv-infected Patients with Invasive Fungal Infections: Data from the Prospective Antifungal Therapy Alliance Registry, a Multicenter, Observational Study

D. Horn, H. Meier‐Kriesche, S. Huprikar, 2022 .

H. Meier‐Kriesche, B. Kaplan, R. Gordon, 2004 .

Blood pressure in the first year following renal transplantation is associated with immunosuppressive regimens: Evidence from the symphony study

J. Schold, P. Halloran, H. Meier‐Kriesche, 2007 .

Early immunosuppression exposure and incidence of acute rejection and renal function progression: Evidence from the symphony study

J. Schold, P. Halloran, H. Meier‐Kriesche, 2007 .

Solid Organ Allograft Survival Improvement in the United States: The Long‐Term Does Not Mirror the Dramatic Short‐Term Success

H. Meier‐Kriesche, S. Lodhi, Kenneth E. Lamb, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of IVIG administration on complement activation and HLA antibody levels

H. Meier‐Kriesche, G. Burke, P. Ruiz, 2010, Transplant International.

Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant.

J. Schold, A. Sehgal, H. Meier‐Kriesche, 2009, Clinical journal of the American Society of Nephrology : CJASN.

THE EFFECT OF GENDER ON KETOCONAZOLE INDUCED CHANGES IN TACROLIMUS PHARMACOKINETICS.: Abstract# 192 Poster Board #‐Session: P39‐I

Julie A. Johnson, A. Gaber, H. Meier‐Kriesche, 2000 .

Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival.

A. Loupy, H. Meier‐Kriesche, R. Mannon, 2024, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes

J. Podichetty, A. Loupy, H. Meier‐Kriesche, 2023, Transplant international : official journal of the European Society for Organ Transplantation.

Temporary removal: Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes.

J. Podichetty, A. Loupy, H. Meier‐Kriesche, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study.

J. Schold, P. Halloran, H. Meier‐Kriesche, 2009, Clinical journal of the American Society of Nephrology : CJASN.